$ARDX Eh Im going on a hunch from reading the PR data etc, But this looks like a FDA delay with a new date, Not a total CRL They filled additional data requested by FDA in April as well as covered all three pivotal trials across 1,000 patients, all which met their primary and key secondary endpoints Same play as CCXI if peeps remember
11
15
15 Likes